Omeprazole Teva Pharma

Omeprazole, the active ingredient in Omeprazole Teva Pharma, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease, peptic ulcer disease and Zollinger‑Ellison syndrome in adults.

GNH USA supplies Omeprazole Teva Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole Teva Pharma is a proton‑pump inhibitor that acts on gastric acid secretion pathways. It is indicated for: - Gastro‑esophageal reflux disease (GERD): alleviates heartburn and promotes healing of the oesophageal lining. - Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with gastrin‑secreting tumors. - Erosive esophagitis: heals erosive damage to the oesophagus caused by acid reflux. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain or discomfort. - Flatulence: excess gas. - Constipation: infrequent.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis. - Acute interstitial nephritis: kidney inflammation. - Hypomagnesemia: low serum magnesium levels. - Fracture risk: increased risk of hip, wrist or vertebral fractures with long‑term use. - Stevens‑Johnson syndrome/TEN: severe skin reactions. - Hepatic dysfunction: elevated liver enzymes or hepatitis.

When prescribing Omeprazole, clinicians should consider several safety aspects.

- Assess renal and hepatic function: adjust use if impairment is present. - Review concomitant medications: potential for drug‑drug interactions. - Limit duration of therapy: use the lowest effective dose for the shortest period. - Monitor for vitamin B12 deficiency with long‑term use. - Evaluate bone health in patients at risk for fractures. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Omeprazole can affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk. - Atazanavir: decreased absorption, loss of antiviral efficacy. - Dasatinib: lowered plasma concentrations, reduced therapeutic effect.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, monitor coagulation. - Phenytoin: decreased serum levels, monitor seizure control. - Methotrexate: increased exposure, especially at high doses, monitor toxicity.